Baxter shares rise after U.S. FDA approves new infusion pump
Mar 31, 2024 .
- Admin** Medical device manufacturer Baxter InternationalBAXShares rose 2.3% to $43.7 pre-market
** The company said (link) that the U.S. FDA has approved the launch of its large-volume infusion pump Novum IQ LVP
** Novum IQ LVP can control the infusion of fluids, medications, parenteral nutrition, blood, and blood products.
** BAX also said the FDA has cleared its Dose IQ safety software, which features a system to reduce dosing errors
** As of the close of the previous day, the stock price had increased by 10.6